Levin Capital Strategies, L.P. Uro Gen Pharma Ltd. Transaction History
Levin Capital Strategies, L.P.
- $990 Million
- Q2 2025
A detailed history of Levin Capital Strategies, L.P. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 1,000 shares of URGN stock, worth $18,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$18,590% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
147Shares Held
41.6MCall Options Held
116KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$81.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$71.3 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$59.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$42.8 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$40.8 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $423M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...